Table 5.

Interactions between conventional antibiotics and LPC-058 at 0.25×, 0.5× and 1× MIC against E. coli producing CTX-M-15 ESBL and K. pneumoniae, P. aeruginosa and A. baumannii producing KPC-2, VIM-1 and OXA-23 carbapenemases, respectively

StrainMultiple of the MIC of conventional antibioticsCombination effect, time in h
multiple of the MIC of LPC-058
0.25×0.5×
E. coli CTX-M-15CTX 0.5×synergy, 9 hsynergy, 6 hindifference
AMK 0.25×synergy, 9 hsynergy, 9 hindifference
CIP 0.5×synergy, 6 hsynergy, 6 hindifference
K. pneumoniae KPC-2CTX 0.25×indifferencesynergy, 24 hsynergy, 24 h
IPM 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
CIP 0.5×indifferenceindifferencesynergy, 24 h
P. aeruginosa VIM-1CAZ 0.5×synergy, 6 hsynergy, 9 hsynergy, 24 h
IPM 0.125×synergy, 6 hasynergy, 9 hsynergy, 24 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 24 h
CIP 0.25×indifferenceindifferencesynergy, 24 h
A. baumannii OXA-23IPM 0.5×NDsynergy, 3 hsynergy, 3 h
AMK 0.062×NDindifferenceindifference
CIP 0.5×NDsynergy, 6 hasynergy, 6 h
StrainMultiple of the MIC of conventional antibioticsCombination effect, time in h
multiple of the MIC of LPC-058
0.25×0.5×
E. coli CTX-M-15CTX 0.5×synergy, 9 hsynergy, 6 hindifference
AMK 0.25×synergy, 9 hsynergy, 9 hindifference
CIP 0.5×synergy, 6 hsynergy, 6 hindifference
K. pneumoniae KPC-2CTX 0.25×indifferencesynergy, 24 hsynergy, 24 h
IPM 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
CIP 0.5×indifferenceindifferencesynergy, 24 h
P. aeruginosa VIM-1CAZ 0.5×synergy, 6 hsynergy, 9 hsynergy, 24 h
IPM 0.125×synergy, 6 hasynergy, 9 hsynergy, 24 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 24 h
CIP 0.25×indifferenceindifferencesynergy, 24 h
A. baumannii OXA-23IPM 0.5×NDsynergy, 3 hsynergy, 3 h
AMK 0.062×NDindifferenceindifference
CIP 0.5×NDsynergy, 6 hasynergy, 6 h

CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; AMK, amikacin; CIP, ciprofloxacin; ND, not determined.

aBacterial regrowth at 24 h.

Table 5.

Interactions between conventional antibiotics and LPC-058 at 0.25×, 0.5× and 1× MIC against E. coli producing CTX-M-15 ESBL and K. pneumoniae, P. aeruginosa and A. baumannii producing KPC-2, VIM-1 and OXA-23 carbapenemases, respectively

StrainMultiple of the MIC of conventional antibioticsCombination effect, time in h
multiple of the MIC of LPC-058
0.25×0.5×
E. coli CTX-M-15CTX 0.5×synergy, 9 hsynergy, 6 hindifference
AMK 0.25×synergy, 9 hsynergy, 9 hindifference
CIP 0.5×synergy, 6 hsynergy, 6 hindifference
K. pneumoniae KPC-2CTX 0.25×indifferencesynergy, 24 hsynergy, 24 h
IPM 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
CIP 0.5×indifferenceindifferencesynergy, 24 h
P. aeruginosa VIM-1CAZ 0.5×synergy, 6 hsynergy, 9 hsynergy, 24 h
IPM 0.125×synergy, 6 hasynergy, 9 hsynergy, 24 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 24 h
CIP 0.25×indifferenceindifferencesynergy, 24 h
A. baumannii OXA-23IPM 0.5×NDsynergy, 3 hsynergy, 3 h
AMK 0.062×NDindifferenceindifference
CIP 0.5×NDsynergy, 6 hasynergy, 6 h
StrainMultiple of the MIC of conventional antibioticsCombination effect, time in h
multiple of the MIC of LPC-058
0.25×0.5×
E. coli CTX-M-15CTX 0.5×synergy, 9 hsynergy, 6 hindifference
AMK 0.25×synergy, 9 hsynergy, 9 hindifference
CIP 0.5×synergy, 6 hsynergy, 6 hindifference
K. pneumoniae KPC-2CTX 0.25×indifferencesynergy, 24 hsynergy, 24 h
IPM 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 9 h
CIP 0.5×indifferenceindifferencesynergy, 24 h
P. aeruginosa VIM-1CAZ 0.5×synergy, 6 hsynergy, 9 hsynergy, 24 h
IPM 0.125×synergy, 6 hasynergy, 9 hsynergy, 24 h
AMK 0.5×synergy, 9 hsynergy, 9 hsynergy, 24 h
CIP 0.25×indifferenceindifferencesynergy, 24 h
A. baumannii OXA-23IPM 0.5×NDsynergy, 3 hsynergy, 3 h
AMK 0.062×NDindifferenceindifference
CIP 0.5×NDsynergy, 6 hasynergy, 6 h

CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; AMK, amikacin; CIP, ciprofloxacin; ND, not determined.

aBacterial regrowth at 24 h.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close